Mechanisms of Hypoglycemia in Patients Without Diabetes
NCT04428723 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 33
Last updated 2026-02-06
Summary
The goal of this study is to identify physiologic and molecular mechanisms that underlie hypoglycemia in the absence of diabetes (or medications that can cause hypoglycemia) and to investigate potential genetic and microbiome differences which contribute to hypoglycemia. We will test the hypothesis that hypoglycemia in the absence of diabetes is linked to genetic variation or the microbiome, and identify whether additional medical history or diagnoses are enriched in the population of patients with hypoglycemia.
Conditions
Interventions
- OTHER
-
Entry of demographic and medical history data into a deidentified database
Entry into repository for analysis.
- GENETIC
-
Blood sample for DNA analysis
Targeted resequencing of DNA to identify variants associated with hypoglycemia, comparing participants with hypoglycemia (both surgical and non-surgical) and healthy controls.
- DIAGNOSTIC_TEST
-
Stool sample for microbiome analysis
Participants will be asked to provide a fecal sample, collected at home, which will be analyzed to determine the types of bacteria present in the feces.
- DIAGNOSTIC_TEST
-
Mixed meal tolerance test
For a subset of participants: After an overnight fast, participants will be given a standard liquid mixed meal; blood samples will be collected at baseline (fasting) and at defined time points after a meal for metabolic and hormonal analyses.
- DIAGNOSTIC_TEST
-
Continuous glucose monitoring
A CGM sensor (Dexcom G4 or other professional version available at onset of study) will be placed in blinded (masked) mode, and will be worn for 10 days. Data will be analyzed to determine patterns of glucose during both day and night intervals.
- DIAGNOSTIC_TEST
-
activity monitor
The activity monitor (Fitbit Charge 2) will be worn by participants for 10 days, to assess activity, concurrent with CGM sensor wear.
Sponsors & Collaborators
-
Joslin Diabetes Center
lead OTHER
Principal Investigators
-
Mary Elizabeth Patti, MD · Joslin Diabetes Center
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2020-08-11
- Primary Completion
- 2026-12-31
- Completion
- 2026-12-31
Countries
- United States
Study Locations
More Related Trials
-
Correlation of Continuous Glucose Monitoring and Glucose Tolerance Testing With Pregnancy Outcomes
NCT00850135 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Continuous Glucose Monitoring to Reduce Hypoglycemia and Improve Safety After Gastric Surgery
NCT03353415 ·Status: COMPLETED ·Phase: NA
-
Study of How Low Blood Sugar Affects the Way Blood Vessels Work
NCT00373854 ·Status: COMPLETED
-
Impact of Hypoglycemia Unawareness on Brain Metabolism Cognition in T1DM
NCT00575783 ·Status: COMPLETED
-
Performance of the Dexcom Continuous Glucose Monitoring (CGM) System in Pregnant Women With Diabetes Mellitus
NCT04905628 ·Status: UNKNOWN
-
Investigation Into the Effects Upon Brain Response to Change in Circulating Glucose Levels in Diabetes Mellitus
NCT00580710 ·Status: COMPLETED
-
Inpatient Closed-loop Glucose Control
NCT01819844 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Continuous Glucose Monitoring in Neonates With Hypoglycemia
NCT02300285 ·Status: TERMINATED ·Phase: NA
-
Examining The Role of CGM in T2DM
NCT01614262 ·Status: COMPLETED ·Phase: NA
-
CGM (Continuous Glucose Monitoring) Use in Diagnosis of Spontaneous and Reactive Hypoglycaemia
NCT04452396 ·Status: TERMINATED ·Phase: NA
-
The Effects of Normobaric Hypoxia on Blood Glucose Levels.
NCT01302782 ·Status: WITHDRAWN
-
Relevance of Reactive Hypoglycemia During an OGTT in Everyday Life Using Continuous Glucose Measurement
NCT06182527 ·Status: COMPLETED ·Phase: NA
-
Continuous Glucose Monitoring of Hospitalized Patients With Diabetes
NCT04230694 ·Status: COMPLETED ·Phase: NA
-
The CGM-OGTT Glycemic Homeostasis Study
NCT07288372 ·Status: NOT_YET_RECRUITING
-
Role of CGMS Usage in Predicting Risk for Hypoglycemia
NCT03481530 ·Status: COMPLETED
-
Incidence of Hypoglycaemia Events in Patients With Stable Insulin-treated Type 2 Diabetes Mellitus Based on Continuous Glucose Monitoring
NCT05461716 ·Status: UNKNOWN
-
Blood Glucose Stability and Variability on Two Diets
NCT01443143 ·Status: UNKNOWN ·Phase: NA
-
Continuous Glucose Monitoring (CGM) in Long Term Care (LTC) Facilities
NCT05711108 ·Status: COMPLETED
-
Investigation Into the Effects of Blood Glucose Levels Upon Eating Behavior in Lean and Obese Non-diabetic and Diabetic Subjects
NCT02673203 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Glycemic Control Using Adjunctive Continuous Glucose Monitoring With the Dexcom G4 System
NCT01627210 ·Status: COMPLETED
-
Continuous Glucose Monitoring in Type 2 Diabetes Mellitus
NCT01083043 ·Status: COMPLETED
-
Incidence of Hypoglycemia in Pregnant Ladies With or Without Gestational Diabetes Fasting Ramadan
NCT04862390 ·Status: COMPLETED
-
Continuous Glucose Monitoring for Various Degrees of Glucose Intolerance
NCT05491954 ·Status: UNKNOWN
-
Testing State of the Art Remote Glucose Monitoring at Diabetes Camp
NCT01680653 ·Status: COMPLETED ·Phase: NA
-
The Different Response of Endocrine Hormones to Hypoglycemia in Patients With Type 1 or Type 2 Diabetes
NCT05290207 ·Status: COMPLETED